109 related articles for article (PubMed ID: 7826086)
21. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
23. Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.
Panetta A; Angelelli B; Martoni A
Anticancer Res; 1999; 19(1B):765-8. PubMed ID: 10216490
[TBL] [Abstract][Full Text] [Related]
24. [Studies on pharmacokinetics of platinum after internal iliac artery infusion of cisplatin in rabbits].
Kanamori Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jan; 45(1):31-7. PubMed ID: 8436840
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
Yamakawa Y; Fujimura M; Hidaka T; Hori S; Saito S
Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476
[TBL] [Abstract][Full Text] [Related]
26. [Study of serum CDDP concentrations in patients with advanced or recurrent adeno-or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV)].
Yagihashi A; Sasaki K; Hirata K; Yamamitsu S
Gan To Kagaku Ryoho; 1996 Jan; 23(1):63-7. PubMed ID: 8546471
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetics of adriamycin vaginal suppository in uterine cervical cancer].
Noda T; Kiyozuka Y; Katakami Y; Ninomiya Y; Saitoh S; Nakanishi A; Ushioda E; Ichijo M; Donoue K; Uehara Y
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):479-85. PubMed ID: 3954372
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin and oxaliplatin cytotoxic effects in sensitive and cisplatin-resistant human cervical tumor cells: time and mode of application dependency.
Martelli L; Ragazzi E; Di Mario F; Basato M; Martelli M
Anticancer Res; 2009 Oct; 29(10):3931-7. PubMed ID: 19846931
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081
[TBL] [Abstract][Full Text] [Related]
30. [Clinical pharmacokinetic study of cisplatin in enhancing cervical cancer radiosensitivity].
Lu JL; Yang F
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1170-2. PubMed ID: 16939913
[TBL] [Abstract][Full Text] [Related]
31. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
32. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum.
Marnitz S; Schmittel A; Bolbrinker J; Schmidt FP; Fons G; Kalache K; Schneider A; Köhler C
Fertil Steril; 2009 Nov; 92(5):1748.e1-4. PubMed ID: 19765705
[TBL] [Abstract][Full Text] [Related]
33. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
34. [CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report].
Beppu M; Hiura M; Nogawa T; Kawakami Y; Yokoyama T; Chiba T
Gan To Kagaku Ryoho; 1998 May; 25(6):933-6. PubMed ID: 9617335
[TBL] [Abstract][Full Text] [Related]
35. [Improvement in the regimen for combined CDDP and CPT-11 chemotherapy].
Shimizu A; Sugitoh Y; Hasegawa A; Okubo K; Fujihara T; Ishikawa T; Suzuki N; Yoda A; Narabayashi A; Takahashi J; Notake Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1807-11. PubMed ID: 11086417
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
[TBL] [Abstract][Full Text] [Related]
37. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
38. [Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
Kochbati L; Ben Ammar CN; Benna F; Hechiche M; Boussen H; Besbes M; Ben Abdallah M; Rahal K; Ben Ayed F; Ben Romdhane K; Maalej M
Tunis Med; 2005 Mar; 83(3):146-9. PubMed ID: 15929442
[TBL] [Abstract][Full Text] [Related]
39. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
Moore KN; Herzog TJ; Lewin S; Giuntoli RL; Armstrong DK; Rocconi RP; Spannuth WA; Gold MA
Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
[TBL] [Abstract][Full Text] [Related]
40. First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study.
Ghaemmaghami F; Behtash N; Yarandi F; Moosavi A; Modares M; Toogeh G; Khanafshar N
J Obstet Gynaecol; 2003 Jul; 23(4):422-5. PubMed ID: 12881087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
